The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies-Reference-Cited by-同舟云学术

The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies

Published:2017-07-19 Issue:9 Volume:33 Page:1605-1613
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Goldman Mitchell¹,Hirsch Ian¹,Zangrilli James G.¹,Newbold Paul²,Xu Xiao¹

Affiliation:

1. AstraZeneca, Gaithersburg, MD, USA;

2. MedImmune LLC, Gaithersburg, MD, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1347091

Reference32 articles.

1. Global asthma prevalence in adults: findings from the cross-sectional world health survey

2. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

3. Global Initiative for Asthma. Global strategy for asthma management and prevention; 2017. http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/. Accessed March 27, 2017

4. Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment

5. Risk factors for death in patients with severe asthma

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics in Asthma;Immunology and Allergy Clinics of North America;2024-09

2. Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study);Pediatric Allergy and Immunology;2024-03

3. Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab;ERJ Open Research;2024-01-26

4. A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspective;Journal of Managed Care & Specialty Pharmacy;2023-11

5. GEMA 5.3. Spanish Guideline on the Management of Asthma;Open Respiratory Archives;2023-10